TABLE 2.
Stem cell type of MSC-EVs | Type of EVs | Target tissue | Biomolecules/Signaling pathways | Mechanism of treatment effect | References | |
---|---|---|---|---|---|---|
1 | MSC | EVs | Muscle | Ca2+, ERK 1/2 | ERK1/2 in muscle tissue is necessary for calcium signaling, but not in the spinal cord | Levin and Borodinsky, (2022) |
2 | ADSC | EVs | Skin | ADSC-EVs, MMP-9 | ADSC-EVs inhibit downregulating MMP-9 and improve collagen deposition | Wang et al. (2022) |
3 | ADSC | Exos | Nerve | ADSC-Exos | Enhance the expression and differentiation of PC12 cells into neurons | Shariati Najafabadi et al. (2021) |
4 | BMMSC | Exos | Vessel | Wnt3a | BMMSC-Exos transport Wnt3a exteriorly and enhance dermal fibroblast proliferation, migration, and angiogenesis in vitro | McBride et al. (2017) |
5 | BMMSC | Exos | Bone | Wnt/β-catenin signaling pathway, Exos | BMMSC-Exo loaded with Wnt can activate Wnt/β-Catenin signal transduction and alleviate bone loss caused by radiation | Zuo et al. (2019) |
6 | BMMSC | EVs | Bone | Cordycepin | Cordycepin promotes osteogenesis of BMMSCs and accelerates fracture healing via hypoxia | Li et al. (2020) |
7 | DPSC ADSC | EVs | Bone | ERK1/2, JNK, MAPK signaling pathway | When DPSC is co cultured with ADSC, the osteogenic ability is significantly enhanced. DPSC-EV can promote the osteogenic differentiation of ADSC through MAPK pathway by enhancing the phosphorylation of ERK1/2 and JNK | Jin et al. (2020) |
8 | MSC | Exos | Bone | miRNA | MSC-EVs pretreated with TNF-α can change miRNA composition, thereby controlling macrophage phenotype to control inflammatory balance and promote osteogenesis | Kang et al. (2022) |
9 | MSC | Exos | Bone | MAPK signaling pathway | MSC-Exo could promote the proliferation of hFOB 1.19 through MAPK signaling pathway, thus alleviating the progression of osteoporosis | Zhao et al. (2018) |
10 | BMMSC | EVs | Cartilage | TNF-α, COX-2, collagenase | BMMSC-EV can down regulate TNF-α mediated COX-2 and pro-inflammatory interleukin levels inhibit collagenase activity and promote cartilage regeneration | Vonk et al. (2018) |
11 | MSC | Exos | Cartilage | Akt/Bad/Bcl-2 signaling pathway | PRP-Exos have the capability to prevent GC-induced apoptosis in a rat model of ONFH by promoting Bcl-2 expression via the Akt/Bad/Bcl-2 signal pathway under ER stress | Tao et al. (2017a) |
12 | hUCMSC | Exos | Skin | Wnt4 | hUCMSC-Exo contributes to skin wound healing by transmitting Wnt4 | Zhang et al. (2015) |
13 | hUCMSC | Exos | Skin | TGF-β1/Smad 2/3 signaling pathway | hUCMSC-Exo suppress dermal fbroblasts-myofbroblats transition via inhibiting the TGF-β1/Smad 2/3 signaling pathway | Hu et al. (2020) |
14 | MSC | EVs | Skin | miR-29a-3p | MSC-EVs alleviate systemic sclerosis via miR-29a-3p | Rozier et al. (2021) |
15 | DPSC | Exos | Tooth | miRNAs, TGF-β1/smads signaling pathway | Lineage specific exosomes can transfer miRNA in TGFbeta1/smads signaling pathway to induce odontogenic differentiation of human dental pulp stem cells | Hu et al. (2019) |
16 | PDLSC | Exos | Periodontal | miRNA-155-5p, Th17 Treg | In chronic periodontitis, exosomal microRNA-155-5p in PDLSCs can be used to regulate sirtuin-1 to achieve Th17/Treg balance | Zheng et al. (2019) |
17 | DPSC | EVs | Periodontal | miRNA-378a, Hedgehog/Gli1 signaling pathway | Periodontitis-compromised DPSCs secrete EVs carrying miRNA-378a promote local angiogenesis by targeting Sufu to activate the Hedgehog/Gli1 signaling | Zhou et al. (2021) |
18 | SHED BMMSC | Exos | Periodontal | Runx2, p-Smad5 | SHED-Exo directly promoted BMMSC osteogenesis, differentiation and bone formation | Wei et al. (2020) |
19 | BMMSC | Exos | Periodontal | Akt/ERK signaling pathway | MSC exosomes can increase PDL cell migration and proliferation through CD73 mediated adenosine receptor activation of survival promoting Akt and ERK signaling | Chew et al. (2019) |
Note: Biomolecules/Signaling pathways refers to the biomolecules or signaling pathways through which MSC-EVs, work out in target tissue.